Trial of NanoPac Intratumoral Injection in Lung Cancer

Clinical trial NCT04314895 · COMPLETED

Trial details

NCT number: NCT04314895
Sponsor: NanOlogy, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell Lung Cancer Lung Cancer, Small Cell Neoplasm of Lung

Start date: 2021-04-14
Primary completion: 2023-09-26
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.